CYP1A inhibition in fish gill filaments: A novel assay applied on pharmaceuticals and other chemicals

Aquatic Toxicology

Volumn 96, Issue 2, 2010, Pages 145-150

  Beijer, Kristina ^a   Abrahamson, Alexandra ^a   Brunström, Björn ^a   Brandt, Ingvar ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antifungal azoles; CYP inhibition; EROD activity; Gill filament assay; Pharmaceuticals; Three spined stickleback

Indexed keywords

ACACETIN; ANTIFUNGAL AGENT; BETA NAPHTHOFLAVONE; BITERTANOL; CYTOCHROME P450 1A; ELLIPTICINE; ETHOXYRESORUFIN DEETHYLASE; KETOCONAZOLE; MICONAZOLE; OMEPRAZOLE; UNCLASSIFIED DRUG;

BIOASSAY; BIOMARKER; CATALYST; CONCENTRATION (COMPOSITION); CYTOCHROME; DRUG; EXPERIMENTAL STUDY; FISH; INHIBITION; MEASUREMENT METHOD;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME MECHANISM; EX VIVO STUDY; FISH; GASTEROSTEUS ACULEATUS; GILL; IC 50; NONHUMAN; PRIORITY JOURNAL; WATER POLLUTANT;

ANIMALS; ANTIFUNGAL AGENTS; CYTOCHROME P-450 CYP1A1; ELLIPTICINES; ENZYME INHIBITORS; GILLS; OMEPRAZOLE; SMEGMAMORPHA; TOXICITY TESTS; WATER POLLUTANTS, CHEMICAL;

GASTEROSTEUS ACULEATUS; MAMMALIA;

EID: 74449083127     PISSN: 0166445X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquatox.2009.10.018     Document Type: Article

References (60)

1. Aimova D., and Stiborova M. Antitumor drug ellipticine inhibits the activities of rat hepatic cytochromes P450. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 149 (2005) 437-440
2. Andersson C., Katsiadaki I., Lundstedt-Enkel K., and Örberg J. Effects of 17α-ethynylestradiol on EROD activity, spiggin and vitellogenin in three-spined stickleback (Gasterosteus aculeatus). Aquat. Toxicol. 83 (2007) 33-42
3. Andersson T., and Pärt P. Benzo[a]pyrene metabolism in isolated perfused rainbow trout gills. Mar. Environ. Res. 28 (1989) 3-7
4. Andreozzi R., Raffaele M., and Nicklas P. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50 (2003) 1319-1330
5. Besse J.P., and Garric J. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation. Toxicol. Lett. 176 (2008) 104-123
6. Brady J.F., Xiao F., Wang M.-H., Li Y., Ning S.M., Gapac J.M., et al. Effects of disulfiram on hepatic P450IIE1, other microsomal enzymes, and hepatotoxicity in rats. Toxicol. Appl. Pharmacol. 108 (1991) 366-373
7. Bucheli T.D., and Fent K. Induction of cytochrome P450 as a biomarker for environmental contamination in aquatic ecosystems. Crit. Rev. Environ. Sci. Technol. 25 (1995) 201-268
8. Buser H.R., Poiger T., and Muller M.D. Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake. Environ. Sci. Technol. 32 (1998) 3449-3456
9. Chan P.K., Lu S.Y., Liao J.W., Wei C.F., Tsai Y., and Ueng T.H. Induction and inhibition of cytochrome P450-dependent monooxygenases of rats by fungicide bitertanol. Food Chem. Toxicol. 44 (2006) 2047-2057
10. Chaudhary A., and Willet K.L. Inhibition of human cytochrome CYP1 enzymes by flavonoids of St. John's wort. Toxicology 217 (2006) 194-205
11. Daughton C.G., and Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Perspect. 107 Suppl. 6 (1999) 907-938
12. DellaGreca M., Iesce M.R., Previtera L., Rubino M., Temussi F., and Brigante M. Degradation of lansoprazole and omeprazole in the aquatic environment. Chemosphere 63 (2006) 1087-1093
13. Denison M.S., and Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 309-334
14. Diaz D., Fabre I., Daujat M., Saint Aubert B., Bories P., Michel H., et al. Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology 99 (1990) 737-747
15. Doostdar H., Burke M.D., and Mayer R.T. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 144 (2000) 31-38
16. Dorne J.L., Skinner L., Frampton G.K., Spurgeon D.J., and Ragas A.M. Human and environmental risk assessment of pharmaceuticals: differences, similarities, lessons from toxicology. Anal. Bioanal. Chem. 387 (2007) 1259-1268
17. Fent K., Weston A.A., and Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 76 (2006) 122-159
18. Frye R.F., and Branch R.A. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects. Br. J. Clin. Pharmacol. 53 (2002) 155-162
19. Gagné F., Blaise C., and André C. Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout (Oncorhynchus mykiss) hepatocytes. Ecotoxicol. Environ. Saf. 64 (2006) 329-336
20. Goksøyr A., and Förlin L. The cytochrome P-450 system in fish, aquatic toxicology and environmental monitoring. Aquat. Toxicol. 22 (1992) 287-311
21. Gomez M.J., Malato O., Ferrer I., Aguera A., and Fernandez-Alba A.R. Solid-phase extraction followed by liquid chromatography-time-of-flight-mass spectrometry to evaluate pharmaceuticals in effluents. A pilot monitoring study. J. Environ. Monit. 9 (2007) 718-729
22. Guengerich F.P., Kim D.H., and Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4 (2002) 168-179
23. Gyllenhammar I., Eriksson H., Söderqvist A., Lindberg R.H., Fick J., and Berg C. Clotrimazole exposure modulates aromatase activity in gonads and brain during gonadal differentiation in Xenopus tropicalis frogs. Aquat. Toxicol. 91 (2009) 102-109
24. Hasselberg L., Westerberg S., Wassmur B., and Celander M.C. Ketoconazole, an antifungal imidazole, increases the sensitivity of rainbow trout to 17[alpha]-ethynylestradiol exposure. Aquat. Toxicol. 86 (2008) 256-264
25. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 131 (2002) 5-17
26. Hegelund T., Ottosson K., Radinger M., Tomberg P., and Celander M.C. Effects of the antifungal imidazole ketoconazole on CYP1A and CYP3A in rainbow trout and killifish. Environ. Toxicol. Chem. 23 (2004) 1326-1334
27. Hirsch R., Ternes T., Haberer K., and Kratz K.-L. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 225 (1999) 109-118
28. Jönsson E.M., Abrahamson A., Brunström B., and Brandt I. Cytochrome P4501A induction in rainbow trout gills and liver following exposure to waterborne indigo, benzo[a]pyrene and 3,3′,4,4′,5-pentachlorobiphenyl. Aquat. Toxicol. 79 (2006) 226-232
29. Jönsson E.M., Brandt I., and Brunström B. Gill filament-based EROD assay for monitoring waterborne dioxin-like pollutants in fish. Environ. Sci. Technol. 36 (2002) 3340-3344
30. Jönsson E.M., Brunström B., Ingebrigtsen K., and Brandt I. Cell-specific CYP1A expression and benzo[a]pyrene adduct formation in gills of rainbow trout (Oncorhynchus mykiss) following CYP1A induction in the laboratory and in the field. Environ. Toxicol. Chem. 23 (2004) 874-882
31. Jönsson M.E., Brunström B., and Brandt I. The zebrafish gill model: induction of CYP1A, EROD and PAH adduct formation. Aquat. Toxicol. 91 (2009) 62-70
32. Kan P.B., Hirst M.A., and Feldman D. Inhibition of steroidogenic cytochrome P-450 enzymes in rat testis by ketoconazole and related imidazole anti-fungal drugs. J. Steroid Biochem. 23 (1985) 1023-1029
33. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 36 (2002) 1202-1211
34. Laville N., Ait-Aissa S., Gomez E., Casellas C., and Porcher J.M. Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes. Toxicology 196 (2004) 41-55
35. Lesca P., Rafidinarivo R., Lecointe P., and Mansuy D. A class of strong inhibitors of microsomal monooxygenases: the ellipticines. Chem. Biol. Interact. 24 (1978) 189-198
36. Levine S.L., Czosnyka H., and Oris J.T. Effects of the fungicide clotrimazole on the bioconcentration of benzo(a)pyrene in gizzard shad (Dorosoma Cepedianum): in vivo and in vitro inhibition of cytochrome P4501A activity. Environ. Toxicol. Chem. 16 (1997) 306-311
37. Levine S.L., and Oris J.T. CYP1A expression in liver and gill of rainbow trout following waterborne exposure: implications for biomarker determination. Aquat. Toxicol. 46 (1999) 279-287
38. Lu C., and Li A.P. Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog. Chem. Biol. Interact. 134 (2001) 271-281
39. McKim J., Schmieder P., and Veith G. Absorption dynamics of organic chemical transport across trout gills as related to octanol-water partition coefficient. Toxicol. Appl. Pharmacol. 77 (1985) 1-10
40. Miranda C.L., Henderson M.C., and Buhler D.R. Evaluation of chemicals as inhibitors of trout cytochrome P450s. Toxicol. Appl. Pharmacol. 148 (1998) 237-244
41. Miyazawa M., and Hisama M. Antimutagenic activity of flavonoids from Chrysanthemum morifolium. Biosci. Biotechnol. Biochem. 67 (2003) 2091-2099
42. Mortensen S.R., Johnson K.A., Weisskopf C.P., Hooper M.J., Lacher T.E., and Kendall R.J. Avian exposure to pesticides in Costa Rican banana plantations. Bull. Environ. Contam. Toxicol. 60 (1998) 562-568
43. Nikolaou A., Meric S., and Fatta D. Occurrence patterns of pharmaceuticals in water and wastewater environments. Anal. Bioanal. Chem. 387 (2007) 1225-1234
44. Rogerson T.D., Wilkinson C.F., and Hetarski K. Steric factors in the inhibitory interaction of imidazoles with microsomal enzymes. Biochem. Pharmacol. 26 (1977) 1039-1042
45. Ronis M.J., Ingelman-Sundberg M., and Badger T.M. Induction, suppression and inhibition of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus virginianus) by ergosterol biosynthesis inhibiting fungicides (EBIFs). Biochem. Pharmacol. 48 (1994) 1953-1965
46. Rotchell J.M., Steventon G.B., and Bird D.J. Catalytic properties of CYP1A isoforms in the liver of an agnathan (Lampetra fluviatilis) and two species of teleost (Pleuronectes flesus, Anguilla anguilla). Comp. Biochem. Physiol. C: Pharmacol. Toxicol. Endocrinol. 125 (2000) 203-214
47. Santen R.J., Van den Bossche H., Symoens J., Brugmans J., and DeCoster R. Site of action of low dose ketoconazole on androgen biosynthesis in men. J. Clin. Endocrinol. Metab. 57 (1983) 732-736
48. Shimada T., and Guengerich F.P. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons. Chem. Res. Toxicol. 19 (2006) 288-294
49. Singh R.P., Agrawal P., Yim D., Agarwal C., and Agarwal R. Acacetin inhibits cell growth and cell cycle progression, and induces apoptosis in human prostate cancer cells: structure-activity relationship with linarin and linarin acetate. Carcinogenesis 26 (2005) 845-854
50. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32 (1998) 3245-3260
51. Thibaut R., Schnell S., and Porte C. The interference of pharmaceuticals with endogenous and xenobiotic metabolizing enzymes in carp liver: an in vitro study. Environ. Sci. Technol. 40 (2006) 5154-5160
52. Tixier C., Singer H.P., Oellers S., and Muller S.R. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ. Sci. Technol. 37 (2003) 1061-1068
53. Trösken E.R., Scholz K., Lutz R.W., Völkel W., Zarn Jr. A., and Lutz W.K. Comparative assessment of the inhibition of recombinant human CYP19 (aromatase) by azoles used in agriculture and as drugs for humans. Endocrinol. Res. 30 (2004) 387-394
54. Trösken E.R., Fischer K., Völkel W., and Lutz W.K. Inhibition of human CYP19 by azoles used as antifungal agents and aromatase inhibitors, using a new LC-MS/MS method for the analysis of estradiol product formation. Toxicology 219 (2006) 33-40
55. Vanden Bossche H., Koymans L., and Moereels H. P450 inhibitors of use in medical treatment: focus on mechanisms of action. Pharmacol. Ther. 67 (1995) 79-100
56. Vanden Bossche H., Moereels H., and Koymans L.M. Aromatase inhibitors-mechanisms for non-steroidal inhibitors. Breast Cancer Res. Treat. 30 (1994) 43-55
57. Weigel S., Berger U., Jensen E., Kallenborn R., Thoresen H., and Hühnerfuss H. Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 56 (2004) 583-592
58. Weigel S., Kuhlmann J., and Hühnerfuss H. Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea. Sci. Total Environ. 295 (2002) 131-141
59. Wolkers J., Jørgensen E.H., Nijmeijer S.M., and Witkamp R.F. Time-dependent induction of two distinct hepatic cytochrome P4501A catalytic activities at low temperatures in Arctic charr (Salvelinus alpinus) after oral exposure to benzo(a)pyrene. Aquat. Toxicol. 35 (1996) 127-138
60. Zomorodi K., and Houston J.B. Selectivity of omeprazole inhibition towards rat liver cytochromes P450. Xenobiotica 27 (1997) 49-58